-
Je něco špatně v tomto záznamu ?
Identifying the neurodevelopmental and psychiatric signatures of genomic disorders associated with intellectual disability: a machine learning approach
N. Donnelly, A. Cunningham, SM. Salas, M. Bracher-Smith, S. Chawner, J. Stochl, T. Ford, FL. Raymond, V. Escott-Price, MBM. van den Bree
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem, Research Support, N.I.H., Extramural
Grantová podpora
MR/L011166/1
Medical Research Council - United Kingdom
U01 MH119738
NIMH NIH HHS - United States
Department of Health - United Kingdom
MR/T033045/1
Medical Research Council - United Kingdom
MR/N022572/1
Medical Research Council - United Kingdom
NLK
BioMedCentral
od 2010-12-01
BioMedCentral Open Access
od 2010
Directory of Open Access Journals
od 2010
Free Medical Journals
od 2010
PubMed Central
od 2010
ProQuest Central
od 2015-01-01
Open Access Digital Library
od 2010-01-01
Open Access Digital Library
od 2010-01-01
Nursing & Allied Health Database (ProQuest)
od 2015-01-01
Health & Medicine (ProQuest)
od 2015-01-01
Family Health Database (ProQuest)
od 2015-01-01
Psychology Database (ProQuest)
od 2015-01-01
Public Health Database (ProQuest)
od 2015-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2010
Springer Nature OA/Free Journals
od 2010-12-01
- MeSH
- dítě MeSH
- genomika MeSH
- kohortové studie MeSH
- lidé MeSH
- mentální retardace * MeSH
- mladiství MeSH
- poruchy autistického spektra * MeSH
- průřezové studie MeSH
- strojové učení MeSH
- Check Tag
- dítě MeSH
- lidé MeSH
- mladiství MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Research Support, N.I.H., Extramural MeSH
BACKGROUND: Genomic conditions can be associated with developmental delay, intellectual disability, autism spectrum disorder, and physical and mental health symptoms. They are individually rare and highly variable in presentation, which limits the use of standard clinical guidelines for diagnosis and treatment. A simple screening tool to identify young people with genomic conditions associated with neurodevelopmental disorders (ND-GCs) who could benefit from further support would be of considerable value. We used machine learning approaches to address this question. METHOD: A total of 493 individuals were included: 389 with a ND-GC, mean age = 9.01, 66% male) and 104 siblings without known genomic conditions (controls, mean age = 10.23, 53% male). Primary carers completed assessments of behavioural, neurodevelopmental and psychiatric symptoms and physical health and development. Machine learning techniques (penalised logistic regression, random forests, support vector machines and artificial neural networks) were used to develop classifiers of ND-GC status and identified limited sets of variables that gave the best classification performance. Exploratory graph analysis was used to understand associations within the final variable set. RESULTS: All machine learning methods identified variable sets giving high classification accuracy (AUROC between 0.883 and 0.915). We identified a subset of 30 variables best discriminating between individuals with ND-GCs and controls which formed 5 dimensions: conduct, separation anxiety, situational anxiety, communication and motor development. LIMITATIONS: This study used cross-sectional data from a cohort study which was imbalanced with respect to ND-GC status. Our model requires validation in independent datasets and with longitudinal follow-up data for validation before clinical application. CONCLUSIONS: In this study, we developed models that identified a compact set of psychiatric and physical health measures that differentiate individuals with a ND-GC from controls and highlight higher-order structure within these measures. This work is a step towards developing a screening instrument to identify young people with ND-GCs who might benefit from further specialist assessment.
Centre for Academic Mental Health Population Health Sciences University of Bristol Bristol UK
Department of Kinanthropology Charles University Prague Czechia
Department of Medical Genetics University of Cambridge Cambridge UK
Department of Psychiatry University of Cambridge Cambridge UK
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23011391
- 003
- CZ-PrNML
- 005
- 20230801133022.0
- 007
- ta
- 008
- 230718s2023 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1186/s13229-023-00549-2 $2 doi
- 035 __
- $a (PubMed)37221545
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Donnelly, Nicholas $u Centre for Academic Mental Health, Population Health Sciences, University of Bristol, Bristol, UK $u MRC Integrative Epidemiology Unit, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK $1 https://orcid.org/0000000322348545
- 245 10
- $a Identifying the neurodevelopmental and psychiatric signatures of genomic disorders associated with intellectual disability: a machine learning approach / $c N. Donnelly, A. Cunningham, SM. Salas, M. Bracher-Smith, S. Chawner, J. Stochl, T. Ford, FL. Raymond, V. Escott-Price, MBM. van den Bree
- 520 9_
- $a BACKGROUND: Genomic conditions can be associated with developmental delay, intellectual disability, autism spectrum disorder, and physical and mental health symptoms. They are individually rare and highly variable in presentation, which limits the use of standard clinical guidelines for diagnosis and treatment. A simple screening tool to identify young people with genomic conditions associated with neurodevelopmental disorders (ND-GCs) who could benefit from further support would be of considerable value. We used machine learning approaches to address this question. METHOD: A total of 493 individuals were included: 389 with a ND-GC, mean age = 9.01, 66% male) and 104 siblings without known genomic conditions (controls, mean age = 10.23, 53% male). Primary carers completed assessments of behavioural, neurodevelopmental and psychiatric symptoms and physical health and development. Machine learning techniques (penalised logistic regression, random forests, support vector machines and artificial neural networks) were used to develop classifiers of ND-GC status and identified limited sets of variables that gave the best classification performance. Exploratory graph analysis was used to understand associations within the final variable set. RESULTS: All machine learning methods identified variable sets giving high classification accuracy (AUROC between 0.883 and 0.915). We identified a subset of 30 variables best discriminating between individuals with ND-GCs and controls which formed 5 dimensions: conduct, separation anxiety, situational anxiety, communication and motor development. LIMITATIONS: This study used cross-sectional data from a cohort study which was imbalanced with respect to ND-GC status. Our model requires validation in independent datasets and with longitudinal follow-up data for validation before clinical application. CONCLUSIONS: In this study, we developed models that identified a compact set of psychiatric and physical health measures that differentiate individuals with a ND-GC from controls and highlight higher-order structure within these measures. This work is a step towards developing a screening instrument to identify young people with ND-GCs who might benefit from further specialist assessment.
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mladiství $7 D000293
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 12
- $a mentální retardace $7 D008607
- 650 12
- $a poruchy autistického spektra $7 D000067877
- 650 _2
- $a kohortové studie $7 D015331
- 650 _2
- $a průřezové studie $7 D003430
- 650 _2
- $a genomika $7 D023281
- 650 _2
- $a strojové učení $7 D000069550
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a Research Support, N.I.H., Extramural $7 D052061
- 700 1_
- $a Cunningham, Adam $u Division of Psychological Medicine and Clinical Neurosciences, Centre for Neuropsychiatric Genetics and Genomics, Institute of Psychological Medicine and Clinical Neurosciences, Cardiff University School of Medicine, Hadyn Ellis Building, Maindy Road, Cathays, Cardiff, CF24 4HQ, UK $1 https://orcid.org/0000000297917813
- 700 1_
- $a Salas, Sergio Marco $u Division of Psychological Medicine and Clinical Neurosciences, Centre for Neuropsychiatric Genetics and Genomics, Institute of Psychological Medicine and Clinical Neurosciences, Cardiff University School of Medicine, Hadyn Ellis Building, Maindy Road, Cathays, Cardiff, CF24 4HQ, UK $1 https://orcid.org/0000000246360322
- 700 1_
- $a Bracher-Smith, Matthew $u Division of Psychological Medicine and Clinical Neurosciences, Centre for Neuropsychiatric Genetics and Genomics, Institute of Psychological Medicine and Clinical Neurosciences, Cardiff University School of Medicine, Hadyn Ellis Building, Maindy Road, Cathays, Cardiff, CF24 4HQ, UK $1 https://orcid.org/0000000205316309
- 700 1_
- $a Chawner, Samuel $u Division of Psychological Medicine and Clinical Neurosciences, Centre for Neuropsychiatric Genetics and Genomics, Institute of Psychological Medicine and Clinical Neurosciences, Cardiff University School of Medicine, Hadyn Ellis Building, Maindy Road, Cathays, Cardiff, CF24 4HQ, UK $1 https://orcid.org/0000000225902874
- 700 1_
- $a Stochl, Jan $u Department of Psychiatry, University of Cambridge, Cambridge, UK $u Department of Kinanthropology, Charles University, Prague, Czechia $1 https://orcid.org/0000000296939930 $7 jx20090130018
- 700 1_
- $a Ford, Tamsin $u Department of Psychiatry, University of Cambridge, Cambridge, UK $1 https://orcid.org/0000000152954904
- 700 1_
- $a Raymond, F Lucy $u Department of Medical Genetics, University of Cambridge, Cambridge, UK $1 https://orcid.org/0000000326523355
- 700 1_
- $a Escott-Price, Valentina $u Division of Psychological Medicine and Clinical Neurosciences, Centre for Neuropsychiatric Genetics and Genomics, Institute of Psychological Medicine and Clinical Neurosciences, Cardiff University School of Medicine, Hadyn Ellis Building, Maindy Road, Cathays, Cardiff, CF24 4HQ, UK $1 https://orcid.org/0000000317845483
- 700 1_
- $a van den Bree, Marianne B M $u Division of Psychological Medicine and Clinical Neurosciences, Centre for Neuropsychiatric Genetics and Genomics, Institute of Psychological Medicine and Clinical Neurosciences, Cardiff University School of Medicine, Hadyn Ellis Building, Maindy Road, Cathays, Cardiff, CF24 4HQ, UK. vandenBreeMB@cardiff.ac.uk $1 https://orcid.org/0000000244263254
- 773 0_
- $w MED00207607 $t Molecular autism $x 2040-2392 $g Roč. 14, č. 1 (2023), s. 19
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37221545 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230718 $b ABA008
- 991 __
- $a 20230801133019 $b ABA008
- 999 __
- $a ok $b bmc $g 1963672 $s 1197656
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 14 $c 1 $d 19 $e 20230523 $i 2040-2392 $m Molecular autism $n Mol Autism $x MED00207607
- GRA __
- $a MR/L011166/1 $p Medical Research Council $2 United Kingdom
- GRA __
- $a U01 MH119738 $p NIMH NIH HHS $2 United States
- GRA __
- $p Department of Health $2 United Kingdom
- GRA __
- $a MR/T033045/1 $p Medical Research Council $2 United Kingdom
- GRA __
- $a MR/N022572/1 $p Medical Research Council $2 United Kingdom
- LZP __
- $a Pubmed-20230718